Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 6367
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
68696
Why is the phII trial not on clinicaltrials . gov
kerdom
02/24/2021 8:14:44 AM
68695
Awesome post Mo! I see it playing out pretty much
(5)
Ultimate
02/24/2021 7:31:35 AM
68693
My opinion on the number of B-CV19 trials is as
(20)
Mo
02/24/2021 1:11:57 AM
68692
I agree that Leo has missed a few PR
(1)
thefamilyman
02/24/2021 12:57:59 AM
68691
Leo put out quite a few PRs last year. Many some
(2)
Commando911
02/23/2021 11:47:56 PM
68690
Thank-you Pete, as usual a killer
angeli
02/23/2021 10:47:57 PM
68688
My take on "the market" is that retail are pawns
(11)
petemantx
02/23/2021 7:10:01 PM
68686
Speculation: I am also intrigued by the word
(4)
doubleJ23
02/23/2021 1:23:51 PM
68685
Ive been checking that site regularly.
Patchesohoulihan
02/23/2021 11:21:13 AM
68682
"it wont be long before we hear something."
(7)
farrell
02/23/2021 10:54:06 AM
68681
Don't get all hung up trying to parse language.
(4)
Drano
02/23/2021 10:23:05 AM
68680
Like I mentioned before, I also want additional
(6)
Ultimate
02/23/2021 10:10:32 AM
68678
Hi all, I'm trying to do some DD and see if there
(2)
doubleJ23
02/23/2021 9:46:24 AM
68675
A good and respected friend sent me this note
(10)
petemantx
02/22/2021 8:19:20 PM
68674
My take on todays events and 10-Q filing is
(13)
Mo
02/22/2021 5:47:17 PM
68673
I think the FDA is going to be trying very hard
(5)
Drano
02/22/2021 4:42:33 PM
68672
Just saw Fauci giving an update with a lot of
(4)
Chemdeps
02/22/2021 4:03:31 PM
68671
With the amount of people needed to fill the 120
(2)
petemantx
02/22/2021 3:56:07 PM
68670
Thats exactly as I see it. We are out of 1st
(2)
Ultimate
02/22/2021 3:00:50 PM
68669
Last week there was a document that showed 17, so
Drano
02/22/2021 2:48:13 PM
68668
Drano......I agree that common sense would tell
(1)
falcon74
02/22/2021 2:10:23 PM
68667
There are 17 clinical trial sites in Russia. I
(1)
Drano
02/22/2021 1:38:59 PM
68666
Chem---- I completely agree with your
(5)
falcon74
02/22/2021 1:04:10 PM
68665
I thought the statement that the phase II trials
(3)
Chemdeps
02/22/2021 12:52:08 PM
68664
Pete From the AS agreement. (i) Development
(3)
bettingbig
02/22/2021 12:18:54 PM
68663
Here's a list of "highlights" from the 10Q that I
(6)
Drano
02/22/2021 12:02:10 PM
68661
Is a successful P1 by AS considered a milestone
(1)
petemantx
02/22/2021 11:50:58 AM
68659
A little something MORE to look forward to.
(4)
NotRichYet2
02/22/2021 11:45:20 AM
68658
Excellent news! I thought covid impacted the
(7)
Ultimate
02/22/2021 11:44:47 AM
68657
"The Company is collaborating with a Regional
(10)
Drano
02/22/2021 11:44:07 AM
68656
10Q great news: " In January 2021, Alfasigma
(10)
Drano
02/22/2021 11:41:44 AM
68654
A phase2/3 or 3 wouldnt be possible if there
(2)
Ultimate
02/22/2021 11:19:04 AM
68651
Perhaps they are testing for other viruses also.
Fit007
02/22/2021 10:02:20 AM
68643
Maybe a ph3 with EUA in Russia. One can wonder.
(1)
zdubble17
02/22/2021 9:34:35 AM
68641
Thanks. That's one hell of an extension to end
(1)
crashco
02/22/2021 9:28:25 AM
68640
https://clinline.ru/reestr-klinicheskih-issledova
zdubble17
02/22/2021 9:26:02 AM
68638
I believe the trial has been extended
(1)
zdubble17
02/22/2021 9:24:57 AM
68634
I have been stressing on other sites that
(7)
petemantx
02/21/2021 8:02:20 PM
68633
24 days since our last press release. In a trial
(6)
Ultimate
02/21/2021 7:20:20 PM
68632
Article talking about investing in vaccines and
pizza
02/21/2021 7:01:04 PM
68631
Many past trials have shown the safety of
(8)
petemantx
02/21/2021 12:11:38 PM
68630
In my opinion,I am looking at the "developments"
(11)
Kelt
02/21/2021 11:27:07 AM
68629
https://pubmed.ncbi.nlm.nih.gov/33572467/ Dated
(1)
stocker11
02/21/2021 10:22:04 AM
68628
https://www.nytimes.com/2021/02/19/opinion/covid-
(3)
crashco
02/21/2021 7:44:43 AM
68627
Same. Most here know why I invested in 2012. So I
(3)
Commando911
02/20/2021 10:26:01 PM
68626
The link to the entire article on MicrocapDaily:
(9)
someconcerns
02/20/2021 12:24:00 PM
68625
Yes......another outstanding post by Pete!!! I
(8)
falcon74
02/20/2021 11:54:58 AM
68624
Thank you for that well thought out and inspiring
(8)
Ultimate
02/20/2021 11:38:19 AM
68623
Post I made this AM in regards to a good write up
(13)
petemantx
02/20/2021 10:22:26 AM
68620
Just a few problems for da shorts! Go
(6)
AlanC
02/19/2021 7:24:12 PM
Newer
Older
Recent Articles
Exciting Acquisition: Brightcove, Inc. Joins Forces with Bending Spoons
PharmaNutra S.p.A. Expands Distribution in North America
Rhodes Martin Partners with Mersen to Enhance Electrical Solutions
Ivalua Partnering with CRIT for Enhanced Spend Management
DotVista: Revolutionizing Accessibility with AI Image Tech
Industrial Inkjet Printers Market Projected to Hit $11.22B
Kuehn Law Advocates for Shareholders of Selected Companies
Changpeng Zhao Warns of Risks in Meme Coin Investments
Discovering the Unique Terpene Profile of Tilray's Platinum Pavé
Eli Lilly's Stock Surge Linked to New Anti-Obesity Initiative
NIO's Journey Towards Profitability: Latest Insights
Tariffs and Market Reactions: What Trump's Plans Mean
Understanding Hercules Capital's P/E Ratio Analysis
Dwight Kay Reveals New Insights with the 1031 Exchange Times
ExchangeRight Expands Portfolio with 13 New Properties
JRW Realty Finalizes Major Property Acquisition with Tractor Supply
Canyon Partners and Gilbane Team Up for New Housing Project
SG Development Hits Major Milestone in Sugar Project Progress
CrowdStrike Expected to Shine with Strong Q3 Performance Insights
Roche's Acquisition of Poseida Therapeutics Signals a New Era
Middleby Corporation Strengthens Its Portfolio with Gorreri Deal
Fondul Proprietatea Narrowing Down AIFM Candidates
Mullen Automotive: A Leap into Refrigerated Electric Trucking
Leadership Changes at Capri Holdings Drive Michael Kors Growth
Canadian Leadership Focuses on Strengthening US Relations
Couche-Tard's Strategic Move for Seven & i Holdings Explained
Three Key Risks That Could Break the Current Market Rally
Poseida Therapeutics' Acquisition by Roche: A Game Changer
Couche-Tard's Ongoing Pursuit of Seven & i Deal Highlights Ambitions
Nippon Steel's Major Acquisition Request: A Plea from Japan's PM
The Future of Investing: Strategies for a Shifting Market Landscape
Comparing Intuitive Machines and Rocket Lab: Who Will Prevail?
Dell Technologies: Insights and Expectations for Upcoming Earnings
United Maritime Shares Q3 2024 Financial Highlights and Outlook
Highmark Health's Impressive Financial Performance in 2024
What to Expect from Frontline's Upcoming Earnings Report
Golden Ocean Group's Upcoming Earnings Report and Insights
Anticipation Builds for QuantaSing Group's Earnings Report
CollPlant Biotechnologies: What to Expect for Earnings Announcements
Analog Devices Reports Strong Q4 Performance Amid Challenges
Bath & Body Works Shows Impressive Growth, Stock Forecasts Rise
Arthur J. Gallagher & Co. Boosts Growth with Strategic Acquisition
Understanding Trump's Tariff Strategies and Market Reactions
Strong Increase in U.S. House Prices Despite Rising Rates
Navigating Currency Markets Amid Tariff Uncertainties
Stereotaxis Showcases Surgical Robotics at Key Conference
Cold Chain Logistics: Market Growth to Reach $1033 Billion
Veru Inc. to Showcase Innovations at Major Medical Conference
Milestone Scientific Gains Approval for Federal Supply Schedule
Wave Life Sciences CEO to Share Insights at Key Conferences